ITRM920361A0 - Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo. - Google Patents

Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo.

Info

Publication number
ITRM920361A0
ITRM920361A0 IT92RM361A ITRM920361A ITRM920361A0 IT RM920361 A0 ITRM920361 A0 IT RM920361A0 IT 92RM361 A IT92RM361 A IT 92RM361A IT RM920361 A ITRM920361 A IT RM920361A IT RM920361 A0 ITRM920361 A0 IT RM920361A0
Authority
IT
Italy
Prior art keywords
active ingredient
pharmaceutical compositions
compositions containing
allylamine compound
allylamine
Prior art date
Application number
IT92RM361A
Other languages
English (en)
Inventor
Friedrich Richter
Michel Steiger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26298929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITRM920361(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB919110884A external-priority patent/GB9110884D0/en
Priority claimed from GB919111477A external-priority patent/GB9111477D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ITRM920361A0 publication Critical patent/ITRM920361A0/it
Publication of ITRM920361A1 publication Critical patent/ITRM920361A1/it
Application granted granted Critical
Publication of IT1260710B publication Critical patent/IT1260710B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
ITRM920361A 1991-05-20 1992-05-12 Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo. IT1260710B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919110884A GB9110884D0 (en) 1991-05-20 1991-05-20 Pharmaceutical compositions
GB919111477A GB9111477D0 (en) 1991-05-29 1991-05-29 Pharmaceutical composition

Publications (3)

Publication Number Publication Date
ITRM920361A0 true ITRM920361A0 (it) 1992-05-12
ITRM920361A1 ITRM920361A1 (it) 1993-11-12
IT1260710B IT1260710B (it) 1996-04-22

Family

ID=26298929

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM920361A IT1260710B (it) 1991-05-20 1992-05-12 Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo.

Country Status (29)

Country Link
US (2) US5681849A (it)
EP (1) EP0515310B1 (it)
JP (1) JP2651311B2 (it)
KR (1) KR100303095B1 (it)
AT (1) AT400517B (it)
AU (1) AU647922B2 (it)
CA (1) CA2068957C (it)
CH (1) CH683823A5 (it)
CY (1) CY1942A (it)
CZ (2) CZ285275B6 (it)
DE (1) DE4215450B4 (it)
DK (1) DK0515310T3 (it)
ES (1) ES2186668T3 (it)
FI (2) FI102458B (it)
FR (1) FR2676646B1 (it)
GB (1) GB2255908B (it)
HK (1) HK148896A (it)
HU (1) HU223343B1 (it)
IE (1) IE70913B1 (it)
IL (1) IL101903A (it)
IT (1) IT1260710B (it)
LU (1) LU88114A1 (it)
MX (1) MX9202328A (it)
NO (1) NO180772C (it)
PT (1) PT515310E (it)
RO (1) RO111986B1 (it)
SA (1) SA92130087B1 (it)
SK (1) SK281615B6 (it)
UA (1) UA39853C2 (it)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
HU219480B (hu) 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
US20020048596A1 (en) * 1994-12-30 2002-04-25 Gregor Cevc Preparation for the transport of an active substance across barriers
EP1039880A1 (en) * 1998-10-23 2000-10-04 Idea Innovative Dermale Applikationen GmbH Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates
ES2173679T3 (es) 1999-01-27 2002-10-16 Idea Ag Inmunizacion/transporte transnasal con vehiculos altamente adaptables.
PT1031346E (pt) 1999-01-27 2002-09-30 Idea Ag Vacinacao nao invasiva atraves da pele
MXPA02000053A (es) * 1999-07-05 2003-07-21 Idea Ag Un metodo para mejorar el tratamiento a traves de barreras adaptables semipermeables.
GB0001928D0 (en) * 2000-01-27 2000-03-22 Novartis Ag Organic compounds
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
DE10011081A1 (de) * 2000-03-09 2001-09-13 Aventis Pharma Gmbh Antiinfektive Wirkstoffkombinationen und ihre Verwendung zur topischen Behandlung von Pilzerkrankungen der Fuß- und Fingernägel
US8257688B2 (en) * 2000-03-27 2012-09-04 Taro Pharmaceuticals Industries Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
US7074392B1 (en) 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
DE10035991A1 (de) 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
KR100389671B1 (ko) * 2000-11-24 2003-06-27 한미약품 주식회사 염산 테르비나핀을 함유하는 항진균제 외용 약제 조성물
US6490390B1 (en) * 2001-01-05 2002-12-03 Phaethon Communications Grating writing systems based on an acousto-optic element
KR100423666B1 (ko) * 2001-02-07 2004-03-18 보령제약 주식회사 항진균 외용 제제
GB0103046D0 (en) 2001-02-07 2001-03-21 Novartis Ag Organic Compounds
GB0108082D0 (en) * 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition
BRPI0101486B1 (pt) * 2001-04-17 2017-09-19 Cristália Produtos Químicos Farmacêuticos Ltda. Pharmaceutical composition for topic use containing heparin for the treatment of skin or mucosal injuries caused by burns
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
US20040105881A1 (en) * 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
EP1663142A2 (en) * 2003-06-23 2006-06-07 MacroChem Corporation Compositons and methods for topical administration
JP5435836B2 (ja) * 2003-07-03 2014-03-05 大正製薬株式会社 外用抗真菌剤組成物
KR100581169B1 (ko) * 2003-07-07 2006-05-17 한국유나이티드제약 주식회사 용해도가 개선된 테르비나핀의 약제조성물 및 그 제조방법
JP2005104916A (ja) * 2003-09-30 2005-04-21 Kobayashi Pharmaceut Co Ltd 抗真菌組成物
EP1706128B1 (en) 2003-12-08 2010-07-21 CPEX Pharmaceuticals, Inc. Pharmaceutical compositions and methods for insulin treatment
US7858115B2 (en) * 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US7618651B2 (en) * 2004-06-24 2009-11-17 Idexx Laboratories Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
US7854943B2 (en) * 2004-06-24 2010-12-21 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
BRPI0512841A (pt) * 2004-07-02 2008-01-08 Warner Lambert Co composições e métodos para o tratamento de infecções patológicas
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
WO2006050926A2 (en) * 2004-11-12 2006-05-18 Idea Ag Extended surface aggregates in the treatment of skin conditions
WO2006103638A2 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Topical pharmaceutical compositions of terbinafine and processes for their preparation
US20090118721A1 (en) * 2005-07-21 2009-05-07 Eric Bornstein Near Infrared Microbial Elimination Laser System (NIMELS)
US7359057B2 (en) * 2005-08-26 2008-04-15 Ball Aerospace & Technologies Corp. Method and apparatus for measuring small shifts in optical wavelengths
AU2006298748B2 (en) 2005-09-29 2010-06-03 Karo Healthcare AB Antifungal composition
JP2010512343A (ja) * 2006-12-08 2010-04-22 オースペックス・ファーマシューティカルズ・インコーポレイテッド 置換アリルアミン類の調製および実用性
CN101677953A (zh) * 2007-02-21 2010-03-24 纸型电池有限公司 用于离子电渗疗法的特比萘芬制剂
WO2008105038A1 (ja) * 2007-02-23 2008-09-04 Nichiban Company Limited 抗真菌症用貼付剤
WO2008121709A1 (en) * 2007-03-30 2008-10-09 Transport Pharmaceuticals, Inc. Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug
US20090082469A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched terbinafine
RU2011111206A (ru) * 2008-10-31 2012-12-10 Моберг Дерма Аб Композиции для местного применения, содержащие комбинацию по меньшей мере двух агентов, усиливающих проникновение
EP2735309B1 (en) 2012-11-27 2016-07-27 Eduardo Cos Alfonso Pharmaceutical composition for the treatment of calcific tendinitis and/or calcific bursitis
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
JP2017536421A (ja) 2014-12-01 2017-12-07 アケリオス セラピューティクス，インコーポレーテッド 片頭痛及び疼痛に関連する状態を処置するための方法及び組成物
GB201511799D0 (en) * 2015-07-06 2015-08-19 Blueberry Therapeutics Ltd Composition and methods of treatment
WO2017106714A1 (en) * 2015-12-16 2017-06-22 Achelios Therapeutics, Inc. Methods and compositions for treating peripheral neuropathy
TWI656883B (zh) * 2017-08-21 2019-04-21 高雄醫學大學 光敏劑或其前驅藥物的醫藥載體

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
DE2716943C2 (de) * 1976-04-28 1986-08-14 Sandoz-Patent-GmbH, 7850 Lörrach N-(3-Phenyl-2-propenyl)-N-(1-naphthylmethyl)-amine, ihre Verwendung und Herstellung
DE3069633D1 (en) * 1979-08-22 1984-12-20 Sandoz Ag Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
FR2572933B1 (fr) * 1981-04-06 1988-03-18 Sandoz Sa Compositions pharmaceutiques topiques a base de tizanidine
JPS6058914A (ja) * 1983-09-12 1985-04-05 Shionogi & Co Ltd イミダゾ−ル系抗真菌性外用ゲル製剤
US4912124A (en) * 1984-02-23 1990-03-27 Ortho Pharmaceutical Corporation Antifungal dermatological solution
JPS61151117A (ja) * 1984-12-25 1986-07-09 Bayer Yakuhin Kk 抗真菌ゲル製剤
US4760096A (en) * 1985-09-27 1988-07-26 Schering Corporation Moisturizing skin preparation
JP2633555B2 (ja) * 1987-03-23 1997-07-23 株式会社東芝 半導体装置の製造方法
ES2038344T3 (es) * 1988-01-13 1993-07-16 Schwarz Pharma Ag Soluciones concentradas de corticoesteroides y metodo para su fabricacion.
US5160737A (en) * 1988-05-03 1992-11-03 Perio Products Ltd. Liquid polymer composition, and method of use
US5116603A (en) * 1989-01-31 1992-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Oral antifungal preventative, and method of use
HUT58201A (en) * 1989-03-03 1992-02-28 Sandoz Ag Process for producing antiphlogistic pharmaceutical composition containing naphtalene-methan-amino derivatives
FR2646603B1 (fr) * 1989-05-03 1991-07-12 Oreal Composition nettoyante
CA2020888A1 (en) * 1989-07-27 1991-01-28 Philippe Guerry Substituted aminoalkoxybenzene derivatives
FR2666962B1 (fr) * 1990-09-26 1996-06-14 Oreal Composition antifongique sous forme de spray sec.
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására

Also Published As

Publication number Publication date
US5681849A (en) 1997-10-28
FI102458B1 (fi) 1998-12-15
IE70913B1 (en) 1997-01-15
HU223343B1 (hu) 2004-06-28
UA39853C2 (uk) 2001-07-16
CA2068957C (en) 2002-12-17
AU1631792A (en) 1992-11-26
FI981777A0 (fi) 1998-08-18
FR2676646A1 (fr) 1992-11-27
HU9201518D0 (en) 1992-07-28
IT1260710B (it) 1996-04-22
NO180772B (no) 1997-03-10
KR100303095B1 (ko) 2001-11-22
ITRM920361A1 (it) 1993-11-12
FR2676646B1 (fr) 1995-05-05
HUT62466A (en) 1993-05-28
IE921599A1 (en) 1992-12-02
AU647922B2 (en) 1994-03-31
NO921958L (no) 1992-11-23
IL101903A (en) 1998-08-16
KR920021139A (ko) 1992-12-18
CS149192A3 (en) 1992-12-16
DE4215450A1 (de) 1992-11-26
US5856355A (en) 1999-01-05
SA92130087B1 (ar) 2006-05-23
CZ283019B6 (cs) 1997-12-17
FI922252A (fi) 1992-11-21
EP0515310A1 (en) 1992-11-25
DK0515310T3 (da) 2003-03-03
NO921958D0 (no) 1992-05-18
PT515310E (pt) 2003-03-31
CA2068957A1 (en) 1992-11-21
MX9202328A (es) 1994-04-29
IL101903A0 (en) 1992-12-30
FI922252A0 (fi) 1992-05-18
FI981777A (fi) 1998-08-18
GB2255908A (en) 1992-11-25
GB9210579D0 (en) 1992-07-01
EP0515310B1 (en) 2002-11-06
DE4215450B4 (de) 2006-04-27
JP2651311B2 (ja) 1997-09-10
CY1942A (en) 1997-05-16
SK281615B6 (sk) 2001-05-10
RO111986B1 (ro) 1997-04-30
ATA102392A (de) 1995-06-15
AT400517B (de) 1996-01-25
HK148896A (en) 1996-08-16
CZ285275B6 (cs) 1999-06-16
NO180772C (no) 1997-06-18
ES2186668T3 (es) 2003-05-16
CH683823A5 (de) 1994-05-31
JPH05132419A (ja) 1993-05-28
FI102458B (fi) 1998-12-15
LU88114A1 (fr) 1993-12-06
GB2255908B (en) 1995-10-04

Similar Documents

Publication Publication Date Title
ITRM920361A0 (it) Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo.
IT8921118A0 (it) Composizione per aerosol comprendente nitroglicerina come ingrediente attivo.
ITRM920476A0 (it) Formulazioni galeniche contenenti ciclosporina.
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
ITBO910024A1 (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
DE69115263D1 (de) Pharmazeutische zusammensetzungen.
DE69326593D1 (de) Landwirtschaftliche chemische Zusammensetzungen
FR2692755B1 (fr) Composition antimicrobienne.
DE69206588D1 (de) Insektizide Zusammensetzungen.
MX9202247A (es) Composiciones de globulos recubiertos con medicamentos de baja solubilidad.
IT1190824B (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
DE69300694D1 (de) Desinfizierende Zusammensetzungen.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
DZ1559A1 (fr) Compositions pharmaceutiques.
IT1290797B1 (it) Composizioni farmaceutiche stabilizzate
ITRM910273A1 (it) Composizione insetticida.
FR2674755B1 (fr) Nouvelles compositions medicamenteuses immunostimulatrices.
DK0469440T3 (da) Faste orale applikationsformer, der som aktivt stof indeholder ifosamid
TR27833A (tr) Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu.
TR27321A (tr) Insektisidal terkip.
DE69103427T2 (de) Chemische zusammensetzungen.
DE69004079D1 (de) Antioxidationszusammensetzungen.
FI923371A0 (fi) En farmaceutisk formulation.
DE69007956T2 (de) Antischwundadditiv enthaltender Dentalwirkstoff.
DE59008309D1 (de) Fungizide Wirkstoffkombinationen.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970526